Swiss Life Asset Management’s Medline Inc MDLN Stock Holding History

Swiss Life Asset Management’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.48M	Buy	+62,848	New	+$2.53M	0.01%	561

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

ECU

Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Swiss Life Asset Management's MDLN Position: Q2 2026 in Review

Swiss Life Asset Management opened a new position in Medline Inc (MDLN) in Q2 2026: 62,848 shares worth $2.48M. The stake represents 0.01% of the portfolio and ranks #561 among its holdings.

229 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

Swiss Life Asset Management held 62,848 shares of Medline Inc worth $2.48M as of Q2 2026.
Medline Inc was a new Swiss Life Asset Management position in Q2 2026.
Medline Inc made up 0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #561 holding.
229 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.